Your browser doesn't support javascript.
loading
Rare but Recurrent ROS1 Fusions Resulting From Chromosome 6q22 Microdeletions are Targetable Oncogenes in Glioma.
Davare, Monika A; Henderson, Jacob J; Agarwal, Anupriya; Wagner, Jacob P; Iyer, Sudarshan R; Shah, Nameeta; Woltjer, Randy; Somwar, Romel; Gilheeney, Stephen W; DeCarvalo, Ana; Mikkelson, Tom; Van Meir, Erwin G; Ladanyi, Marc; Druker, Brian J.
Afiliação
  • Davare MA; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Papé Pediatric Research Institute, Oregon Health and Sciences University, Portland, Oregon. davarem@ohsu.edu.
  • Henderson JJ; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Papé Pediatric Research Institute, Oregon Health and Sciences University, Portland, Oregon.
  • Agarwal A; Knight Cancer Institute, Oregon Health and Sciences University, Portland, Oregon.
  • Wagner JP; Knight Cancer Institute, Oregon Health and Sciences University, Portland, Oregon.
  • Iyer SR; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Papé Pediatric Research Institute, Oregon Health and Sciences University, Portland, Oregon.
  • Shah N; The Ben and Catherine Ivy Center for Advanced Brain Tumor Treatment, Swedish Neuroscience Institute, Seattle Washington.
  • Woltjer R; Department of Pathology, Oregon Health and Sciences University, Portland, Oregon.
  • Somwar R; Department of Pathology, Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Gilheeney SW; Departments of Neurology and Neurosurgery, Henry Ford Hospital, Detroit, Michigan.
  • DeCarvalo A; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Mikkelson T; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Van Meir EG; Departments of Neurosurgery and Hematology & Medical Oncology, School of Medicine and Winship Cancer Institute Emory University, Atlanta, Georgia.
  • Ladanyi M; Department of Pathology, Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Druker BJ; Knight Cancer Institute, Oregon Health and Sciences University, Portland, Oregon.
Clin Cancer Res ; 24(24): 6471-6482, 2018 12 15.
Article em En | MEDLINE | ID: mdl-30171048
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cromossomos Humanos Par 6 / Proteínas Tirosina Quinases / Proteínas de Fusão Oncogênica / Deleção Cromossômica / Proteínas Proto-Oncogênicas / Glioma Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cromossomos Humanos Par 6 / Proteínas Tirosina Quinases / Proteínas de Fusão Oncogênica / Deleção Cromossômica / Proteínas Proto-Oncogênicas / Glioma Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article